Castle Biosciences Beats Q3 Revenue Estimates and Raises Annual Guidance
CSTL Castle Biosciences Inc
$34.38 +5.72%
View chart & analysis → - 1Castle Biosciences reported Q3 revenue of $102.89 million.
- 2Castle Biosciences showed an earnings surprise rate of 65.8%.
- 3Castle Biosciences raised its annual revenue guidance to $385 million-$395 million.
So what's the key point?
Castle Biosciences' Q3 revenue of $102.89 million was much higher than what experts expected. The company has also raised its target for the total amount of money it expects to earn this year.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.